Academic Integrity: tutoring, explanations, and feedback — we don’t complete graded work or submit on a student’s behalf.

Could someone please answer all questions below - please !! Explanation would be

ID: 2781703 • Letter: C

Question

Could someone please answer all questions below - please !! Explanation would be helpful with Calcs ?

Do you have to work out tax rater youself to complete question 3 (EPS part)

shares ak-even analysis) Wesfarmers Lid 4n 30 June 2014, whereas Woolworths Lid (WOW) had 1248 million s 2014 camings levels found in Study Problems operating p f assuming a 30% tax rate for both firms, what is their break-even shares outstanding Given both finms t(ie, the level of EBIT where EPS is the same for both firms? MINI-CASE On 31 January 2014. Sigma (SIP) sheet of financing in its balance net proft of $53.5 million with very little interest expense Sigma Pharmaceuticals Ltd Balance Sheet uticals Ltd (SIP) Moreover, the firm's 2014 income statement reported (resulting from short-term borrowing throughout the year for cash-management purposes) 31 January 2014) Sigma Pharmaceuticals Ltd Income Statements Financial structure (31 January 2014) Liabilities Current liabilities Earnings before interest and tax $70 300 Accounts payable Short-term/current debt Other current liabilities 5353 100 Interest expense Profit before tax 2000 68 300 (14800) $53 500 Report 11 300 5364 400 Income tax expense Net profit Source Signa Pharmaceuticals Ltd, 2013-2014 Aviu Total current liabilities Long-term debt 0 Other long-term iabilities Long-term liabilities Shareholders' equity Lotal liabilities and shareholders squity htp/sigmaco.comauinvestor-relations/sharehalder-services/annua 2000 $ 2000 $578800 If Sigma's management were considering the $945 200 possibility of using significant debt financing for the first time, it might look at CSL. Ltd (CSL.), Australia's largest pharmaceutical company, as a benchmark firm for comparison purposes. CSL used debt financing, as shown S Prarmaceuticats Ltd 2013-2014 Arrual Fuport on the following balance sheet and income statement

Explanation / Answer

ans 1

debt ratio = total debt/total assets where total debt = long term debt + short term debt

(1884700 + 5600)/6277700 = 0.30.This indicvates that 30% of the assets are provided by total debt

intererst bearing debt ratio = long term debt/equity= 1884700/3162000 = 0.60

ans 2

interest coverage ratio = EBIT/interest= 1657300/53000= 31.27 times

This means the company has $o.60 debt for every $ of equity. The company is having higher financial leverage and therefor higher risk as compared to sigma pharmaceuticals, which is a zero debt company

EBITDA coverage ratio=EBITDA/(interest payments+ principal repayments)

1657300 /(   53000+ 200000)= 1657300/ 253000= 6.55 times